| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 13 | 2025 | 40 | 2.440 |
Why?
|
| Transcription Factors | 10 | 2024 | 66 | 1.550 |
Why?
|
| Cell Differentiation | 11 | 2022 | 71 | 1.450 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 6 | 2019 | 12 | 1.390 |
Why?
|
| Myocardium | 9 | 2025 | 34 | 1.380 |
Why?
|
| Mice | 24 | 2025 | 685 | 1.290 |
Why?
|
| Muscular Atrophy | 3 | 2021 | 21 | 1.270 |
Why?
|
| Animals | 29 | 2025 | 1711 | 1.230 |
Why?
|
| Heart | 9 | 2025 | 48 | 1.210 |
Why?
|
| MicroRNAs | 3 | 2022 | 53 | 1.000 |
Why?
|
| Regeneration | 2 | 2024 | 15 | 0.990 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 73 | 0.840 |
Why?
|
| Stem Cells | 4 | 2021 | 33 | 0.840 |
Why?
|
| Muscle Proteins | 4 | 2016 | 11 | 0.820 |
Why?
|
| Embryo, Mammalian | 4 | 2021 | 30 | 0.770 |
Why?
|
| Embryoid Bodies | 1 | 2022 | 1 | 0.760 |
Why?
|
| Transcriptional Activation | 2 | 2019 | 5 | 0.740 |
Why?
|
| Muscle, Skeletal | 3 | 2021 | 78 | 0.730 |
Why?
|
| DNA-Binding Proteins | 3 | 2016 | 22 | 0.710 |
Why?
|
| rho-Associated Kinases | 2 | 2019 | 8 | 0.710 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2021 | 1 | 0.680 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2021 | 3 | 0.680 |
Why?
|
| Signal Transduction | 9 | 2025 | 216 | 0.670 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 10 | 0.670 |
Why?
|
| Myoblasts | 2 | 2019 | 10 | 0.650 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2024 | 39 | 0.640 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 2 | 0.640 |
Why?
|
| Pacemaker, Artificial | 1 | 2020 | 4 | 0.640 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2020 | 8 | 0.630 |
Why?
|
| GATA4 Transcription Factor | 2 | 2018 | 2 | 0.630 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 4 | 0.630 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 9 | 0.620 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 24 | 0.620 |
Why?
|
| Humans | 14 | 2024 | 4936 | 0.610 |
Why?
|
| Cell Nucleus | 2 | 2017 | 16 | 0.610 |
Why?
|
| Peptides | 1 | 2019 | 49 | 0.580 |
Why?
|
| Cells, Cultured | 5 | 2019 | 127 | 0.540 |
Why?
|
| Histone Acetyltransferases | 1 | 2017 | 1 | 0.520 |
Why?
|
| Cell Line | 5 | 2022 | 84 | 0.520 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 17 | 0.510 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 18 | 0.510 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 6 | 0.500 |
Why?
|
| Fibroblasts | 1 | 2016 | 12 | 0.500 |
Why?
|
| Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2016 | 1 | 0.490 |
Why?
|
| Myofibrils | 1 | 2016 | 4 | 0.480 |
Why?
|
| Cell Proliferation | 7 | 2024 | 115 | 0.480 |
Why?
|
| Mice, Knockout | 6 | 2024 | 140 | 0.440 |
Why?
|
| Morphogenesis | 5 | 2025 | 28 | 0.430 |
Why?
|
| Promoter Regions, Genetic | 5 | 2021 | 27 | 0.420 |
Why?
|
| Serum Response Factor | 2 | 2024 | 3 | 0.410 |
Why?
|
| Heart Failure | 2 | 2017 | 30 | 0.380 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 1 | 0.370 |
Why?
|
| Sumoylation | 1 | 2012 | 5 | 0.360 |
Why?
|
| Rats | 3 | 2024 | 241 | 0.350 |
Why?
|
| Cell Lineage | 5 | 2016 | 15 | 0.330 |
Why?
|
| Mesoderm | 4 | 2018 | 7 | 0.310 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 34 | 0.310 |
Why?
|
| Embryonic Stem Cells | 4 | 2017 | 10 | 0.280 |
Why?
|
| Cell Cycle Proteins | 3 | 2017 | 19 | 0.280 |
Why?
|
| Phosphorylation | 2 | 2019 | 48 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 184 | 0.270 |
Why?
|
| Mice, Transgenic | 4 | 2021 | 47 | 0.270 |
Why?
|
| Heart Ventricles | 2 | 2025 | 21 | 0.270 |
Why?
|
| Endocardium | 2 | 2025 | 6 | 0.260 |
Why?
|
| Oxidative Stress | 3 | 2017 | 58 | 0.260 |
Why?
|
| Histone Chaperones | 2 | 2017 | 3 | 0.250 |
Why?
|
| Mouse Embryonic Stem Cells | 2 | 2016 | 5 | 0.250 |
Why?
|
| Sarcolemma | 2 | 2016 | 6 | 0.240 |
Why?
|
| Muscle Development | 2 | 2016 | 13 | 0.240 |
Why?
|
| Male | 7 | 2021 | 2491 | 0.230 |
Why?
|
| Cell Communication | 1 | 2025 | 14 | 0.220 |
Why?
|
| Female | 5 | 2021 | 2523 | 0.220 |
Why?
|
| Integrin beta1 | 1 | 2024 | 10 | 0.220 |
Why?
|
| Fibronectins | 1 | 2024 | 13 | 0.220 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 13 | 0.220 |
Why?
|
| Homeobox Protein Nkx-2.5 | 3 | 2024 | 9 | 0.210 |
Why?
|
| Genes, Reporter | 2 | 2021 | 8 | 0.200 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2013 | 2 | 0.200 |
Why?
|
| Wnt Proteins | 2 | 2013 | 9 | 0.200 |
Why?
|
| Bioreactors | 2 | 2020 | 6 | 0.190 |
Why?
|
| Transcriptome | 3 | 2019 | 43 | 0.190 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 8 | 0.190 |
Why?
|
| NIH 3T3 Cells | 2 | 2019 | 7 | 0.190 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 160 | 0.180 |
Why?
|
| Catalytic Domain | 2 | 2019 | 13 | 0.180 |
Why?
|
| Receptor, Notch1 | 1 | 2021 | 7 | 0.180 |
Why?
|
| Tenascin | 1 | 2021 | 1 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 7 | 0.170 |
Why?
|
| beta-Galactosidase | 1 | 2021 | 3 | 0.170 |
Why?
|
| Microinjections | 1 | 2021 | 2 | 0.170 |
Why?
|
| Recombination, Genetic | 1 | 2021 | 11 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2021 | 47 | 0.170 |
Why?
|
| Chromatin | 2 | 2017 | 7 | 0.160 |
Why?
|
| Mice, SCID | 2 | 2018 | 9 | 0.160 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 225 | 0.160 |
Why?
|
| Adrenergic Agents | 1 | 2020 | 1 | 0.160 |
Why?
|
| Adipogenesis | 1 | 2020 | 2 | 0.160 |
Why?
|
| Epinephrine | 1 | 2020 | 8 | 0.160 |
Why?
|
| Hypoxia | 1 | 2020 | 8 | 0.160 |
Why?
|
| Electric Conductivity | 1 | 2020 | 16 | 0.160 |
Why?
|
| Sequence Homology | 1 | 2019 | 3 | 0.160 |
Why?
|
| Dexamethasone | 1 | 2019 | 7 | 0.160 |
Why?
|
| Gene Expression | 2 | 2017 | 49 | 0.160 |
Why?
|
| Protein Isoforms | 1 | 2019 | 13 | 0.160 |
Why?
|
| Tissue Scaffolds | 1 | 2020 | 8 | 0.160 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 11 | 0.160 |
Why?
|
| Biological Clocks | 1 | 2019 | 9 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 9 | 0.160 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 9 | 0.160 |
Why?
|
| Tissue Engineering | 1 | 2020 | 16 | 0.150 |
Why?
|
| Base Sequence | 1 | 2019 | 63 | 0.150 |
Why?
|
| Kinetics | 1 | 2020 | 80 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 9 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 25 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 16 | 0.150 |
Why?
|
| HeLa Cells | 1 | 2019 | 18 | 0.150 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 19 | 0.150 |
Why?
|
| RNA, Messenger | 1 | 2019 | 68 | 0.150 |
Why?
|
| Protein Binding | 3 | 2015 | 115 | 0.150 |
Why?
|
| Up-Regulation | 2 | 2016 | 28 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2019 | 47 | 0.150 |
Why?
|
| Mutation | 2 | 2019 | 132 | 0.150 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2018 | 1 | 0.140 |
Why?
|
| Pericardium | 1 | 2018 | 3 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 7 | 0.140 |
Why?
|
| Repressor Proteins | 1 | 2018 | 13 | 0.140 |
Why?
|
| Calcinosis | 1 | 2018 | 5 | 0.140 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2018 | 2 | 0.140 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 2 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2018 | 23 | 0.140 |
Why?
|
| Hypertension | 1 | 2019 | 58 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 27 | 0.140 |
Why?
|
| YY1 Transcription Factor | 1 | 2017 | 1 | 0.130 |
Why?
|
| Muscular Diseases | 1 | 2017 | 5 | 0.130 |
Why?
|
| Acetylation | 1 | 2017 | 6 | 0.130 |
Why?
|
| Histones | 1 | 2017 | 12 | 0.130 |
Why?
|
| Trans-Activators | 1 | 2017 | 18 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 14 | 0.130 |
Why?
|
| Heart, Artificial | 1 | 2017 | 1 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 3 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2016 | 3 | 0.130 |
Why?
|
| Wnt3A Protein | 1 | 2016 | 3 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 19 | 0.120 |
Why?
|
| Polyadenylation | 1 | 2016 | 1 | 0.120 |
Why?
|
| Exoribonucleases | 1 | 2016 | 2 | 0.120 |
Why?
|
| Asymmetric Cell Division | 1 | 2016 | 3 | 0.120 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2016 | 1 | 0.120 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2016 | 2 | 0.120 |
Why?
|
| Cyclic GMP | 1 | 2016 | 6 | 0.120 |
Why?
|
| Cardiomegaly | 1 | 2016 | 4 | 0.120 |
Why?
|
| Muscle Strength | 1 | 2016 | 7 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 23 | 0.120 |
Why?
|
| Organ Size | 1 | 2016 | 29 | 0.120 |
Why?
|
| Endoderm | 1 | 2015 | 1 | 0.120 |
Why?
|
| Gene Targeting | 1 | 2015 | 3 | 0.120 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12 | 0.120 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 43 | 0.110 |
Why?
|
| DNA | 1 | 2016 | 58 | 0.110 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 12 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2014 | 1 | 0.110 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 27 | 0.100 |
Why?
|
| Organogenesis | 2 | 2025 | 10 | 0.100 |
Why?
|
| TCF Transcription Factors | 1 | 2013 | 1 | 0.100 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 1 | 0.100 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2013 | 1 | 0.100 |
Why?
|
| Cellular Reprogramming | 1 | 2013 | 1 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 1 | 0.090 |
Why?
|
| Calcium | 1 | 2012 | 31 | 0.090 |
Why?
|
| Cell Movement | 2 | 2024 | 61 | 0.080 |
Why?
|
| Phenotype | 2 | 2021 | 67 | 0.080 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2021 | 8 | 0.070 |
Why?
|
| Integrases | 2 | 2021 | 4 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 48 | 0.070 |
Why?
|
| Nanotubes | 1 | 2025 | 9 | 0.060 |
Why?
|
| Cell Shape | 1 | 2024 | 9 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 46 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2015 | 49 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2021 | 4 | 0.040 |
Why?
|
| Chromosome Walking | 1 | 2021 | 1 | 0.040 |
Why?
|
| Ventricular Myosins | 1 | 2021 | 1 | 0.040 |
Why?
|
| Homozygote | 1 | 2021 | 5 | 0.040 |
Why?
|
| Genome | 1 | 2021 | 20 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 9 | 0.040 |
Why?
|
| Cytokines | 1 | 2021 | 37 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 8 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 8 | 0.040 |
Why?
|
| Connexins | 1 | 2019 | 6 | 0.040 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2019 | 2 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 2 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 30 | 0.040 |
Why?
|
| Phenylurea Compounds | 1 | 2019 | 3 | 0.040 |
Why?
|
| Anilides | 1 | 2019 | 4 | 0.040 |
Why?
|
| beta Catenin | 1 | 2019 | 7 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 14 | 0.040 |
Why?
|
| Computational Biology | 1 | 2019 | 32 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2019 | 20 | 0.040 |
Why?
|
| Pyridines | 1 | 2019 | 23 | 0.040 |
Why?
|
| Quinolines | 1 | 2019 | 21 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 25 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 35 | 0.040 |
Why?
|
| Endocardial Cushions | 1 | 2018 | 1 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 6 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 6 | 0.040 |
Why?
|
| Echocardiography | 1 | 2018 | 9 | 0.040 |
Why?
|
| Alleles | 1 | 2018 | 16 | 0.040 |
Why?
|
| Histone Code | 1 | 2018 | 1 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2018 | 13 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2018 | 15 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2018 | 13 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 35 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 1 | 0.030 |
Why?
|
| Gain of Function Mutation | 1 | 2017 | 2 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2017 | 5 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 66 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2017 | 6 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2017 | 21 | 0.030 |
Why?
|
| CELF1 Protein | 1 | 2016 | 2 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2016 | 7 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 6 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 7 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 125 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 11 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2016 | 4 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 9 | 0.030 |
Why?
|
| DNA Repair | 1 | 2016 | 6 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 9 | 0.030 |
Why?
|
| Fetus | 1 | 2016 | 11 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 26 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 56 | 0.030 |
Why?
|
| Apoptosis | 1 | 2016 | 46 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 6 | 0.030 |
Why?
|
| COS Cells | 1 | 2015 | 3 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 6 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 10 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 318 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2013 | 7 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 22 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 14 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 16 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2013 | 13 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2013 | 1 | 0.030 |
Why?
|
| Point Mutation | 1 | 2013 | 6 | 0.030 |
Why?
|